Logo image of SN

SHARKNINJA INC (SN) Stock Fundamental Analysis

NYSE:SN - New York Stock Exchange, Inc. - KYG8068L1086 - Common Stock - Currency: USD

111.47  +2.47 (+2.27%)

After market: 111.47 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SN. SN was compared to 67 industry peers in the Household Durables industry. SN has a medium profitability rating, but doesn't score so well on its financial health evaluation. SN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SN was profitable.
SN had a positive operating cash flow in the past year.
SN Yearly Net Income VS EBIT VS OCF VS FCFSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 100M 200M 300M 400M

1.2 Ratios

SN has a better Return On Assets (8.48%) than 63.08% of its industry peers.
SN has a better Return On Equity (20.02%) than 80.00% of its industry peers.
SN has a Return On Invested Capital of 13.25%. This is in the better half of the industry: SN outperforms 76.92% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SN is in line with the industry average of 12.03%.
The 3 year average ROIC (10.76%) for SN is below the current ROIC(13.25%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.48%
ROE 20.02%
ROIC 13.25%
ROA(3y)7.24%
ROA(5y)N/A
ROE(3y)14.27%
ROE(5y)N/A
ROIC(3y)10.76%
ROIC(5y)N/A
SN Yearly ROA, ROE, ROICSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 5 10 15

1.3 Margins

The Profit Margin of SN (7.02%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of SN has declined.
SN has a Operating Margin (10.55%) which is comparable to the rest of the industry.
SN's Operating Margin has declined in the last couple of years.
SN's Gross Margin of 47.77% is amongst the best of the industry. SN outperforms 87.69% of its industry peers.
SN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.55%
PM (TTM) 7.02%
GM 47.77%
OM growth 3Y-19.61%
OM growth 5YN/A
PM growth 3Y-30.86%
PM growth 5YN/A
GM growth 3Y-0.5%
GM growth 5YN/A
SN Yearly Profit, Operating, Gross MarginsSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SN is still creating some value.
The number of shares outstanding for SN remains at a similar level compared to 1 year ago.
The debt/assets ratio for SN is higher compared to a year ago.
SN Yearly Shares OutstandingSN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M 100M
SN Yearly Total Debt VS Total AssetsSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 1B 2B 3B

2.2 Solvency

SN has an Altman-Z score of 6.01. This indicates that SN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.01, SN belongs to the top of the industry, outperforming 86.15% of the companies in the same industry.
SN has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.42, SN perfoms like the industry average, outperforming 41.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 6.01
ROIC/WACC1.45
WACC9.12%
SN Yearly LT Debt VS Equity VS FCFSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.67 indicates that SN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.67, SN is not doing good in the industry: 70.77% of the companies in the same industry are doing better.
SN has a Quick Ratio of 1.67. This is a bad value and indicates that SN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SN (0.95) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 0.95
SN Yearly Current Assets VS Current LiabilitesSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500M 1B 1.5B

5

3. Growth

3.1 Past

The earnings per share for SN have decreased strongly by -28.24% in the last year.
Measured over the past years, SN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.11% on average per year.
SN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.43%.
Measured over the past years, SN shows a quite strong growth in Revenue. The Revenue has been growing by 15.61% on average per year.
EPS 1Y (TTM)-28.24%
EPS 3Y-20.11%
EPS 5YN/A
EPS Q2Q%27.37%
Revenue 1Y (TTM)14.43%
Revenue growth 3Y15.61%
Revenue growth 5YN/A
Sales Q2Q%33.25%

3.2 Future

Based on estimates for the next years, SN will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.93% on average per year.
The Revenue is expected to grow by 13.41% on average over the next years. This is quite good.
EPS Next Y35.64%
EPS Next 2Y24.59%
EPS Next 3Y21.29%
EPS Next 5Y19.93%
Revenue Next Year30.79%
Revenue Next 2Y21.2%
Revenue Next 3Y17.55%
Revenue Next 5Y13.41%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SN Yearly Revenue VS EstimatesSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
SN Yearly EPS VS EstimatesSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.44, the valuation of SN can be described as expensive.
SN's Price/Earnings ratio is a bit more expensive when compared to the industry. SN is more expensive than 64.62% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.47. SN is around the same levels.
SN is valuated rather expensively with a Price/Forward Earnings ratio of 22.20.
Based on the Price/Forward Earnings ratio, SN is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
SN is valuated cheaply when we compare the Price/Forward Earnings ratio to 92.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.44
Fwd PE 22.2
SN Price Earnings VS Forward Price EarningsSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

SN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. SN is more expensive than 72.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.21
SN Per share dataSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SN's earnings are expected to grow with 21.29% in the coming years.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y24.59%
EPS Next 3Y21.29%

0

5. Dividend

5.1 Amount

No dividends for SN!.
Industry RankSector Rank
Dividend Yield N/A

SHARKNINJA INC

NYSE:SN (2/4/2025, 8:08:20 PM)

After market: 111.47 0 (0%)

111.47

+2.47 (+2.27%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)10-31 2024-10-31/bmo
Earnings (Next)02-13 2025-02-13/bmo
Inst Owners46.62%
Inst Owner Change1.5%
Ins Owners3.05%
Ins Owner Change0%
Market Cap15.63B
Analysts86
Price Target124.91 (12.06%)
Short Float %5.8%
Short Ratio3.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP41.8%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.29%
Min EPS beat(2)3.19%
Max EPS beat(2)11.38%
EPS beat(4)4
Avg EPS beat(4)6.03%
Min EPS beat(4)3.19%
Max EPS beat(4)11.38%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.99%
Min Revenue beat(2)4.59%
Max Revenue beat(2)11.39%
Revenue beat(4)4
Avg Revenue beat(4)6.77%
Min Revenue beat(4)2.11%
Max Revenue beat(4)11.39%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.63%
PT rev (3m)8.45%
EPS NQ rev (1m)0.79%
EPS NQ rev (3m)11.84%
EPS NY rev (1m)0.2%
EPS NY rev (3m)0.54%
Revenue NQ rev (1m)1.09%
Revenue NQ rev (3m)8.52%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)2.98%
Valuation
Industry RankSector Rank
PE 28.44
Fwd PE 22.2
P/S 3.05
P/FCF N/A
P/OCF 110.25
P/B 8.71
P/tB 31.71
EV/EBITDA 25.21
EPS(TTM)3.92
EY3.52%
EPS(NY)5.02
Fwd EY4.5%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)1.01
OCFY0.91%
SpS36.51
BVpS12.8
TBVpS3.52
PEG (NY)0.8
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.48%
ROE 20.02%
ROCE 19.79%
ROIC 13.25%
ROICexc 13.91%
ROICexgc 27.86%
OM 10.55%
PM (TTM) 7.02%
GM 47.77%
FCFM N/A
ROA(3y)7.24%
ROA(5y)N/A
ROE(3y)14.27%
ROE(5y)N/A
ROIC(3y)10.76%
ROIC(5y)N/A
ROICexc(3y)11.72%
ROICexc(5y)N/A
ROICexgc(3y)30.71%
ROICexgc(5y)N/A
ROCE(3y)16.06%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-19.61%
OM growth 5YN/A
PM growth 3Y-30.86%
PM growth 5YN/A
GM growth 3Y-0.5%
GM growth 5YN/A
F-Score6
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA 1.14
Cap/Depr 138.23%
Cap/Sales 3.06%
Interest Coverage 250
Cash Conversion 21.71%
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 0.95
Altman-Z 6.01
F-Score6
WACC9.12%
ROIC/WACC1.45
Cap/Depr(3y)104.23%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.42%
Cap/Sales(5y)N/A
Profit Quality(3y)62.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.24%
EPS 3Y-20.11%
EPS 5YN/A
EPS Q2Q%27.37%
EPS Next Y35.64%
EPS Next 2Y24.59%
EPS Next 3Y21.29%
EPS Next 5Y19.93%
Revenue 1Y (TTM)14.43%
Revenue growth 3Y15.61%
Revenue growth 5YN/A
Sales Q2Q%33.25%
Revenue Next Year30.79%
Revenue Next 2Y21.2%
Revenue Next 3Y17.55%
Revenue Next 5Y13.41%
EBIT growth 1Y16.23%
EBIT growth 3Y-7.06%
EBIT growth 5YN/A
EBIT Next Year67.23%
EBIT Next 3Y27.38%
EBIT Next 5Y23.34%
FCF growth 1Y34.54%
FCF growth 3Y-13.8%
FCF growth 5YN/A
OCF growth 1Y36.88%
OCF growth 3Y-1.48%
OCF growth 5YN/A